Among the treatment options for CRC, there are oxaliplatin, irinotecan, mitomycin C and fluoropyrimidines, such as 5-fluSousa et al.orouracil (5-FU), in addition to radiotherapy and anti-EGFR monoclonal antibodies, such as cetuximab [2]. The gene discussed is EGFR; the disease is colorectal carcinoma.